HEALTHCARE RESOURCE UTILIZATION (HCRU) AND ASSOCIATED COSTS AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH ORAL AZACITIDINE AS MAINTENANCE AND THOSE ELIGIBLE BUT NOT TREATED USING A US CLAIMS DATABASE

被引:0
|
作者
Borate, U. [1 ]
Seiter, K. [2 ]
Potluri, R. [3 ]
Mazumder, D. [3 ]
Heydendael, W. [4 ]
Chevli, M. [4 ]
Prebet, T. [4 ]
Strocchia, M. [4 ]
Vasconcelos, A. [4 ]
Sieluk, J. [4 ]
机构
[1] Ohio State Univ, Columbus, OH USA
[2] New York Med Coll, Valhalla, NY USA
[3] Putnam Associates, New York, NY USA
[4] Bristol Myers Squibb, Princeton, NJ USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE86
引用
收藏
页码:S67 / S67
页数:1
相关论文
共 50 条
  • [1] Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
    Borate, Uma
    Seiter, Karen
    Potluri, Ravi
    Mazumder, Debasish
    Chevli, Manoj
    Prebet, Thomas
    Gaugler, Lona
    Strocchia, Maria
    Vasconcelos, Alberto
    Sieluk, Jan
    [J]. ADVANCES IN THERAPY, 2024,
  • [2] Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML)
    Tabah, Ashley
    Knoth, Russell
    Huggar, David
    Copher, Ronda M.
    Cao, Zhun
    Lipkin, Craig
    Leblanc, Thomas W.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S181 - S181
  • [3] Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry
    Mukherjee, Sudipto
    Abedi, Mehrdad
    Erba, Harry P.
    Pollyea, Daniel A.
    Roboz, Gail J.
    Thompson, Michael A.
    Louis, Chrystal U.
    Flick, E. Dawn
    Nifenecker, Melissa
    Kiselev, Pavel
    Swern, Arlene S.
    Cogle, Christopher R.
    [J]. BLOOD, 2018, 132
  • [4] Healthcare Resource Utilization and Costs Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Contemporary US Claims
    Huntington, Scott F.
    Chang, Hsien-Yen
    Fu, Alex Z.
    Loefgren, Christina
    Lu, Xiaoxiao
    [J]. BLOOD, 2023, 142
  • [5] Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    [J]. BLOOD, 2021, 138
  • [6] AML-068- Survival Differences in Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine (Oral-AZA) as Maintenance and Those Eligible but Not Treated in a US Electronic Health Record (EHR) Database (vol 23S1, S1-S593, 2023)
    Mims, Alice
    Xie, Zhuoer
    Vasconcelos, Alberto
    Strocchia, Maria
    Heydendael, Willem
    Chevli, Manoj
    Rotter, David
    Potluri, Ravi
    Prebet, Thomas
    Sieluk, Jan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (03): : 203 - 204
  • [7] ANNUAL HEALTHCARE RESOURCE UTILIZATION AND COSTS IN US PATIENTS DIAGNOSED WITH RELAPSED ACUTE MYELOID LEUKEMIA
    Huggar, D.
    Knoth, R. L.
    Cao, Z.
    Lipkin, C.
    Copher, R.
    LeBlanc, T. W.
    [J]. VALUE IN HEALTH, 2021, 24 : S28 - S28
  • [8] Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia
    Tabah, Ashley
    Knoth, Russell L.
    Huggar, David
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    Leblanc, Thomas W.
    [J]. BLOOD, 2020, 136
  • [9] Real -World Healthcare Costs and Resource Utilization Among Patients Treated With Erenumab in the United States: A Retrospective Claims Database Study
    Tepper, Stewart
    Schwedt, Todd
    Vo, Pamela
    Joshi, Parth
    Glassberg, Mrudula
    Abdrabboh, Ahmad
    Ferraris, Matias
    Tiwari, Santosh
    Thompson, Jeffrey
    [J]. NEUROLOGY, 2022, 98 (18)
  • [10] A RETROSPECTIVE DATABASE ANALYSIS OF HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS AMONG PATIENT TREATED WITH RUFINAMIDE IN UK
    Varga, S.
    Tsong, W.
    Jenkins-Jones, S.
    Holden, S. E.
    Morgan, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S344 - S345